Unexpected Rosuvastatin-Canagliflozin Adverse Effect Reported Unexpected Rosuvastatin-Canagliflozin Adverse Effect Reported
Canadian clinicians report the rare case of a 76-year-old woman who had a sharp spike in plasma levels of rosuvastatin within days of starting the SGLT2 inhibitor.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 5, 2020 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

In Rare Cases, Diabetes & Cholesterol Drug Combo Could Be Toxic
MONDAY, Aug. 3, 2020 -- Taking the statin Crestor in combination with the diabetes drug canagliflozin (Invokana) may have the potential to trigger statin toxicity, a new case report suggests. Although this report details the problem in just one... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 3, 2020 Category: General Medicine Source Type: news

FDA Approves Non-Statin Drug That Lowers Cholesterol
TRENTON, N.J. (AP) — U.S. regulators on Friday approved a new type of cholesterol-lowering drug aimed at millions of people who can’t tolerate — or don’t get enough help from — widely used statin pills like Lipitor and Crestor. The Food and Drug Administration approved Esperion Therapeutics Inc.’s Nexletol for people genetically predisposed to have sky-high cholesterol and people who have heart disease and need to further lower their bad cholesterol. The daily pill is to be taken in conjunction with a healthy diet and the highest statin dose patients can handle, the FDA said. High LDL, o...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 24, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston Cholesterol Statins Source Type: news

FDA approves drug that lowers cholesterol in a new way
U.S. regulators have approved a new type of cholesterol-lowering drug aimed at millions of people who don't get enough help from widely used statin pills like Lipitor and Crestor (Source: ABC News: Health)
Source: ABC News: Health - February 22, 2020 Category: Consumer Health News Tags: Health Source Type: news

Adult heart disease after childhood cancer now less likely
Efforts to cut toxicity of treatment credited for drop in heart disease risk in survivors of childhood cancer Related items fromOnMedica Only half of new cancer drugs extend or improve life Women treated for cancer have higher CHF risk in pregnancy Metformin doesn ’t help HbA1c in teens with type 1 diabetes US doctor says FDA should have withdrawn rosuvastatin Codeine not to be used for coughs and colds in children under 12 (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 16, 2020 Category: UK Health Source Type: news

Memory is impaired by prescription blood pressure meds, but pomegranate juice improves blood pressure and cognitive function
(Natural News) Struggling to find clinical benefits for statin drugs and blood pressure medications, a team of researchers put two drug protocols to the test to see their effects on human thinking and memory. The research, funded by the maker of the drugs (AstraZeneca), hoped to find cognitive benefits for candesartan and hydrocholorothiazide, rosuvastatin, or... (Source: NaturalNews.com)
Source: NaturalNews.com - July 10, 2019 Category: Consumer Health News Source Type: news

How thousands of British patients may have taken tainted NHS drugs sold by the mafia
Commonly prescribed drugs were stolen in Italy and then sold to British pharmacists and hospitals, exposing patients to potentially lethal consequences. Among them is statin rosuvastatin. (Source: the Mail online | Health)
Source: the Mail online | Health - June 15, 2019 Category: Consumer Health News Source Type: news

Lipitor (atorvastatin) vs. Crestor (rosuvastatin)
Title: Lipitor (atorvastatin) vs. Crestor (rosuvastatin)Category: MedicationsCreated: 5/15/2019 12:00:00 AMLast Editorial Review: 5/15/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 15, 2019 Category: Cardiology Source Type: news

Half of People Miss Benefits of Statins
Many people who are prescribed statins are at increased risk of cardiovascular disease because they stop taking the drugs. (Source: NYT Health)
Source: NYT Health - May 3, 2019 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Crestor (Drug) Cholesterol Heart Source Type: news

Lowering BP, Lipids in Healthy Elderly Has No Cognitive Effect
WEDNESDAY, Feb. 27, 2019 -- Candesartan plus hydrochlorothiazide, rosuvastatin, or their combination do not impact cognitive decline among older people, according to a study published online Feb. 27 in Neurology. Jackie Bosch, Ph.D., from McMaster... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 27, 2019 Category: Pharmaceuticals Source Type: news

The Health 202: Drug executives may have to defend these expensive medicines to Congress
Think Lyrica, Crestor, Keytruda. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - February 25, 2019 Category: Consumer Health News Authors: Paige Winfield Cunningham Source Type: news

In Latest Physical, Trump Proclaimed Healthy, but Obese In Latest Physical, Trump Proclaimed Healthy, but Obese
The president also has upped his dose of rosuvastatin to 40 mg daily.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 15, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Ezallor (Rosuvastatin Calcium Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 2, 2019 Category: Drugs & Pharmacology Source Type: news

Why the risks and benefits of statins are so complex
Statin side effects can vary depending on your age, sex and type of statin, when the cholesterol-lowering drugs are used to prevent cardiovascular disease, a new study suggests. Atorvastatin and rosuvastatin provided benefits at a lower 10-year risk. (Source: CNN.com - Health)
Source: CNN.com - Health - December 3, 2018 Category: Consumer Health News Source Type: news

Onset of Musculoskeletal Adverse Events Varies Between Statins
MONDAY, Nov. 19, 2018 -- The onset of musculoskeletal adverse events (MAEs) during statin monotherapy is significantly faster with use of atorvastatin and rosuvastatin versus simvastatin, according to a study published online Nov. 7 in Pharmacology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2018 Category: Pharmaceuticals Source Type: news

Daily aspirin not beneficial in healthy adults
Trial looks at risks and benefits of aspirin Related items fromOnMedica Too few women take part in many CVD clinical trials US doctor says FDA should have withdrawn rosuvastatin GPs defend practice on prescribing statins Drugs regulators “put profits before patients” Withdrawn valsartan meds not linked to short-term cancer risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 17, 2018 Category: UK Health Source Type: news

Aug 17, 2018 This Week in Cardiology Aug 17, 2018 This Week in Cardiology
Screening athletes, AF ablation complications, physician gender and MI mortality, the rise of chronic kidney disease, and the rosuvastatin lawsuit are discussed in this week's podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 17, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

AstraZeneca settles Texas drug lawsuits for $110 million
Drugmaker AstraZeneca has agreed to pay $110 million to settle two lawsuits brought by the state of Texas claiming that it fraudulently marketed the antipsychotic drug Seroquel and Crestor for high cholesterol. (Source: Reuters: Health)
Source: Reuters: Health - August 8, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

New drugs shine as AstraZeneca treads path back to growth
AstraZeneca's new drugs performed strongly in the second quarter, offering a glimpse of better times ahead as the company struggles with falling sales of cholesterol fighter Crestor due to generic competition. (Source: Reuters: Health)
Source: Reuters: Health - July 26, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

AstraZeneca sales hit by generic competitors to Crestor statin
Pharma group’s core operating profit falls 47% in first quarter (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 18, 2018 Category: Pharmaceuticals Source Type: news

Gene study spots clues to heart risk for statin patients
(Vanderbilt University Medical Center) A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2018 Category: International Medicine & Public Health Source Type: news

This Cholesterol Drug Combination Might Lower Your Risk of Death, Study Finds
(ORLANDO) — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often. Results on the drug, Praluent, were announced Saturday at an American College of Cardiology conference in Florida. It’s the first time a cholesterol-lowering drug has reduced deaths since statins such as Lipitor and Crestor came out decades ago. “It’s the ultimate outcome; it’s what matters to patients,” said study leader Dr. Philippe Gabriel Steg of Hospital Bichat i...
Source: TIME: Health - March 10, 2018 Category: Consumer Health News Authors: Marilyn Marchione / AP Tags: Uncategorized APH healthytime medicine onetime Source Type: news

The effect of local and systemic statin use as an adjunct to non-surgical and surgical periodontal therapy —A systematic review and meta-analysis
ConclusionsSignificant additional clinical and radiographic improvements are obtained after local, but not systemic, statin use as an adjunct to SRP in deep pockets associated with intrabony defects and seemingly with furcation defects; intrasurgical statin application seems similarly beneficial. Confirmation of these results, and especially of the effect size, from other research groups is warranted. (Source: Dental Technology Blog)
Source: Dental Technology Blog - October 20, 2017 Category: Dentistry Source Type: news

AstraZeneca ’ s Cancer Drug Trial Disappoints, Sending Shares Lower
The treatment had been expected to be a crucial driver of growth for the company as it faces more competition from generic pharmaceuticals. (Source: NYT Health)
Source: NYT Health - July 27, 2017 Category: Consumer Health News Authors: PRASHANT S. RAO Tags: Inventions and Patents Drugs (Pharmaceuticals) Crestor (Drug) AstraZeneca PLC Source Type: news

Heart Attack Survivors Often Fail to Take Statins
Most patients in a large study either took less of the lifesaving medicines than needed or stopped taking the drugs entirely within two years. (Source: NYT Health)
Source: NYT Health - April 24, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Heart Crestor (Drug) Statins (Cholesterol-Lowering Drugs) Source Type: news

Tackling a Decade of Change
There has never been a more exciting time to be in the pharmaceutical industry – if you like change, that is. While change is a constant in business, pharma has experienced unprecedented levels over the past decade, says Alistair Grenfell, President, North Europe, Middle East and Africa, at QuintilesIMS.“At a time when we are seeing a huge amount of innovation in our science and our pipeline – creating great excitement among the healthcare community – we need to acknowledge that our world has changed,” says Grenfell. “If you wind the clock back to 2005 and look at the top 10 selling medi...
Source: EyeForPharma - March 23, 2017 Category: Pharmaceuticals Authors: Hugh Gosling Source Type: news

Zocor (simvastatin) vs. Crestor (rosuvastatin)
Title: Zocor (simvastatin) vs. Crestor (rosuvastatin)Category: MedicationsCreated: 3/17/2017 12:00:00 AMLast Editorial Review: 3/17/2017 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 17, 2017 Category: Cardiology Source Type: news

CardioBreak: Medicare Money for Micra; Stent Retriever Wins, Warnings; Crestor Switcheroo
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 13, 2017 Category: Cardiology Source Type: news

Health Care Special Report: KU doc finds cancer hope
After years of treating patients, researching cancer and testing treatments, Tomoo Iwakuma made the discovery of his lifetime: Statins, typically used to lower cholesterol levels, could treat some types of cancer. An associate professor at the University of Kansas Medical Center, Iwakuma thinks that statins — such as brand names Crestor and Lipitor — could be used to treat 10 to 20 percent of cancer patients with a mutation in a tumor suppressor protein called p53. This mutation is found in… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 3, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

AstraZeneca hit by falling sales of bestsellers
Declines in Crestor and Nexium offset emerging markets growth   (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - February 2, 2017 Category: Pharmaceuticals Source Type: news

Rosuvastatin Calcium Tablets (rosuvastatin calcium) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 12, 2017 Category: Drugs & Pharmacology Source Type: news

Patient With Chest Pain and Shortness of Breath Shows Standardized Treatment Doesn't Work for All Patients
John, a 65-year-old male, is sitting in a chair in the corner of the room as you and your partner enter his house. John tells you he's the only one home and called 9-1-1 because he can't breathe and his chest is killing him. His skin is ashen and his breathing is rapid. You can palpate a weak irregular pulse and you note his skin is warm and diaphoretic. He describes his shortness of breath as increasing in severity over the last couple of hours with the chest discomfort. With a pulse oximetry reading of 78% on room air, you apply oxygen via a non-rebreathing mask. Physical exam reveals bibasilar crackles on pulmonary ausc...
Source: JEMS Patient Care - December 30, 2016 Category: Emergency Medicine Authors: Dennis Edgerly, EMT-P Tags: Columns Patient Care Source Type: news

Statins may influence risk of Alzheimer ’s
Risk reduction depends on specific statin and ethnicity and sex of patient Related items fromOnMedica US doctor says FDA should have withdrawn rosuvastatin Detection bias may be behind memory loss with statins Statins might not cut colorectal cancer risk after all Major review clears statins US expert group updates statins recommendations (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 14, 2016 Category: UK Health Source Type: news

Pharma withheld faulty device info in rivaroxaban trial
Patients must live with uncertainty until concerns over key trial data are addressed Related items fromOnMedica Extending anticoagulation duration cuts risk of VTE recurrence Metformin lowers cardiac deaths better than other drugs US doctor says FDA should have withdrawn rosuvastatin NICE calls for safer use of controlled drugs BMJ questions trial evidence for rivaroxaban (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 29, 2016 Category: UK Health Source Type: news

Rosuvastatin Slows Progression of Atherosclerosis in HIV Rosuvastatin Slows Progression of Atherosclerosis in HIV
Find out what there is to know about the effect of rosuvastatin on subclinical atherosclerosis among HIV-infected individuals receiving antiretroviral therapy.AIDS (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - September 23, 2016 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Crestor (Rosuvastatin Calcium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 1, 2016 Category: Drugs & Pharmacology Source Type: news

A new method cuts the cost of drug-building chemicals
EPFL (École polytechnique fédérale de Lausanne) scientists design a new method to cheaply produce some of the most important chemical compounds in the pharmaceutical industry - the amines. The amines are one of the most important classes of chemical compounds today. Amines that contain a ring-like structure - called an "aryl" group - are used widely in pharmaceuticals, such as the top-selling drugs Abilify, Crestor, Gleevec, and Lidoderm. (Source: World Pharma News)
Source: World Pharma News - August 12, 2016 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

AstraZeneca helped by new drugs as cholesterol pill fades
LONDON (Reuters) - Generic competition to cholesterol buster Crestor in the U.S. market pushed second-quarter core earnings down by nearly a third at drugmaker AstraZeneca, which is now banking on new cancer medicines to revive its fortunes. (Source: Reuters: Health)
Source: Reuters: Health - July 28, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

CardioBreak: Generic Crestor; Specialization Saves Lives; Catheter Recall
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - July 25, 2016 Category: Urology & Nephrology Source Type: news

Morning Break: Generic Crestor OK'd; High Priestess of Snake Oil; Pain Refugees
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - July 21, 2016 Category: Psychiatry Source Type: news

FDA Approves Additional Generic Versions of Rosuvastatin (FREE)
By the Editors The FDA has approved several more generic versions of rosuvastatin (Crestor), the New York Times reports. The first … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 21, 2016 Category: Primary Care Source Type: news

Judge Rules Against AstraZeneca's Plea to Ban Crestor Generics
Generic manufacturers can now enter the $5 billion cholesterol drug market (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 20, 2016 Category: Pharmaceuticals Source Type: news

Judge Rules Against AstraZeneca's Plea to Ban Crestor Generics
Generic manufacturers can now enter the $5 billion cholesterol drug market (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 20, 2016 Category: Pharmaceuticals Source Type: news

Mylan Launches Generic Crestor(R) Tablets
HERTFORDSHIRE, England and PITTSBURGH, July 20, 2016 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Rosuvastatin Calcium Tablets, 5 mg, 10 mg, 20 mg and 40 mg, which is a generic version of A... Biopharmaceuticals, Generics, FDA, Product LaunchMylan, Rosuvastatin, Crestor, AstraZeneca (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 20, 2016 Category: Pharmaceuticals Source Type: news

Generic Crestor Wins Approval, Dealing a Blow to AstraZeneca
The F.D.A. allowed eight generics of the cholesterol-lowering pill to go on the market, a move that should considerably decrease its price. (Source: NYT Health)
Source: NYT Health - July 20, 2016 Category: Consumer Health News Authors: ANDREW POLLACK Tags: Crestor (Drug) Drugs (Pharmaceuticals) Generic Brands and Products AstraZeneca PLC Food and Drug Administration Source Type: news

Sun Pharma gets FDA nod for rosuvastatin calcium tablets
Sun Pharma said: "One of its subsidiaries has received final approval from USFDA for its Abbreviated New Drug Application (ANDA) for generic version of Crestor. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2016 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets FDA nod for rosuvastatin calcium tabs
Aurobindo Pharma has received final approval from the US health regulator USFDA for rosuvastatin calcium tablets, used in lowering cholesterol. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2016 Category: Pharmaceuticals Source Type: news

Glenmark gets FDA nod for rosuvastatin calcium tablets
Quoting IMS sales data for the 12 months to May 2016, Glenmark said Rosuvastatin calcium tablets achieved annual sales of around USD 6.78 billion. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2016 Category: Pharmaceuticals Source Type: news

Judge refuses to block generic versions of AstraZeneca's Crestor
(Reuters) - A U.S. judge on Tuesday refused to issue a temporary restraining order blocking the approval of new generic versions of AstraZeneca's blockbuster cholesterol drug Crestor in the United States. (Source: Reuters: Health)
Source: Reuters: Health - July 20, 2016 Category: Consumer Health News Tags: healthNews Source Type: news